| Volume: | 6,397,946 |
|---|---|
| Day's Low: | $52.84 |
| 52-wk Low: | $41.27 |
| Previous Close: | $52.96 |
| Dividend: | $0.40 |
| Market Cap: | 82,967,000 |
| Avg Volume: | 7,738,400 |
|---|---|
| Day's High: | $53.74 |
| 52-wk High: | $57.39 |
| Open Price: | $53.25 |
| Yield: | 2.98% |
| P/E (Forward): | 14.46 |
| 7:33 PM | 11/20/2009 | UPDATE: FDA Reviewing Safety Of Weight-Loss Drug Meridia |
| 7:03 PM | 11/20/2009 | FDA Reviewing Safety Of Weight-Loss Drug Meridia |
| 2:24 PM | 11/19/2009 | Abbott Hesitates To Promote Niaspan Study Due To FDA Rules |
| 2:45 PM | 11/18/2009 | UPDATE: Study Questions Utility Of Merck Cholesterol Drugs |
| 11:45 AM | 11/18/2009 | Another Study Questions Utility Of Merck Cholesterol Drugs |
| 10:31 AM | 11/17/2009 | FDA Warns Abbott Over Manufacturing Violations At Plant |
| 12:39 PM | 11/16/2009 | For Merck, Effect Of Negative Cholesterol Study Wanes |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.92 | 0.79 | 16.46 |
| EPS, GAAP | 0.95 | 0.69 | 37.68 |
| Consensus Estimate | 0.90 | 0.77 | 16.88 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.61 | 3.32 | 8.73 |
| EPS, GAAP | 3.42 | 2.91 | 17.53 |
| Consensus Estimate | 3.55 | NA | NA |
| ABT | Industry Average | |
| P/E (TTM) | 15.68 | 16.90 |
| P/E (Forward) | 14.46 | 1.10 |
| PEG Ratio | 1.28 | 0.07 |
| Price/Sales | 2.80 | 3.05 |
| Beta | 0.19 | 0.23 |